BioVie Inc. Increase (Decrease) in Employee Related Liabilities
BioVie Inc. (BIVI) reported Increase (Decrease) in Employee Related Liabilities of $229.17 thousand for the 12-month period ending 2018-06-30, per its 10-K filed 2019-09-27.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities · last filed 2019-09-27
- BioVie Inc. increase (decrease) in employee related liabilities for the quarter ending 2018-06-30 was $41.67K, a 33.33% decline year-over-year.
- BioVie Inc. increase (decrease) in employee related liabilities for the quarter ending 2018-03-31 was $62.50K.
- BioVie Inc. increase (decrease) in employee related liabilities for the quarter ending 2017-12-31 was $62.50K, a 0.00% change year-over-year.
- BioVie Inc. increase (decrease) in employee related liabilities for the quarter ending 2017-09-30 was $62.50K, a 0.00% change year-over-year.
- BioVie Inc. increase (decrease) in employee related liabilities for fiscal 2018 was $229.17K, a 719.27% increase from fiscal 2017.
- BioVie Inc. increase (decrease) in employee related liabilities for fiscal 2017 was $27.97K, a 84.17% decline from fiscal 2016.
- BioVie Inc. increase (decrease) in employee related liabilities for fiscal 2016 was $176.66K, a 9.41% increase from fiscal 2015.
- BioVie Inc. increase (decrease) in employee related liabilities for fiscal 2015 was $161.47K, a 0.00% change from fiscal 2014.
| Period end | Increase (Decrease) in Employee Related Liabilities 3 month | Increase (Decrease) in Employee Related Liabilities 6 month | Increase (Decrease) in Employee Related Liabilities 9 month | Increase (Decrease) in Employee Related Liabilities 12 month |
|---|---|---|---|---|
| 2018-06-30 | $41.67K derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-27 | $104.17K derived: sum of 2 quarters · filed 2019-09-27 | $166.67K derived: sum of 3 quarters · filed 2019-09-27 | $229.17K 10-K · filed 2019-09-27 |
| 2018-03-31 | $62.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-10 | $125.00K derived: sum of 2 quarters · filed 2019-05-10 | $187.50K 10-Q · filed 2019-05-10 | $250.00K derived: sum of 4 quarters · filed 2019-05-10 |
| 2017-12-31 | $62.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-12 | $125.00K 10-Q · filed 2019-02-12 | $187.50K derived: sum of 3 quarters · filed 2019-02-12 | $27.97K derived: sum of 4 quarters · filed 2019-02-12 |
| 2017-09-30 | $62.50K 10-Q · filed 2018-11-14 | $125.00K derived: sum of 2 quarters · filed 2018-11-14 | -$34.53K derived: sum of 3 quarters · filed 2018-11-14 | $27.97K derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-06-30 | $62.50K derived: 10-K 12 month − 10-Q 9 month · filed 2018-10-05 | -$97.03K derived: sum of 2 quarters · filed 2018-10-05 | -$34.53K derived: sum of 3 quarters · filed 2018-10-05 | $27.97K 10-K · filed 2018-10-05 |
| 2017-03-31 | -$159.53K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-14 | -$97.03K derived: sum of 2 quarters · filed 2018-05-14 | -$34.53K 10-Q · filed 2018-05-14 | $21.03K derived: sum of 4 quarters · filed 2018-05-14 |
| 2016-12-31 | $62.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-14 | $125.00K 10-Q · filed 2018-02-14 | $180.56K derived: sum of 3 quarters · filed 2018-02-14 | $220.92K derived: sum of 4 quarters · filed 2018-02-14 |
| 2016-09-30 | $62.50K 10-Q · filed 2017-11-08 | $118.06K derived: sum of 2 quarters · filed 2017-11-08 | $158.42K derived: sum of 3 quarters · filed 2017-11-08 | $198.79K derived: sum of 4 quarters · filed 2017-11-08 |
| 2016-06-30 | $55.56K derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-24 | $95.92K derived: sum of 2 quarters · filed 2017-08-24 | $136.29K derived: sum of 3 quarters · filed 2017-08-24 | $176.66K 10-K · filed 2017-08-24 |
| 2016-03-31 | $40.37K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-09 | $80.74K derived: sum of 2 quarters · filed 2017-05-09 | $121.11K 10-Q · filed 2017-05-09 | $161.47K derived: sum of 4 quarters · filed 2017-05-09 |
| 2015-12-31 | $40.37K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2017-02-07 | $80.74K 10-Q · filed 2017-02-07 | $121.11K derived: sum of 3 quarters · filed 2017-02-07 | $161.48K derived: sum of 4 quarters · filed 2017-02-07 |
| 2015-09-30 | $40.37K 10-Q/A · filed 2017-01-19 | $80.74K derived: sum of 2 quarters · filed 2017-01-19 | $121.11K derived: sum of 3 quarters · filed 2017-01-19 | $161.47K derived: sum of 4 quarters · filed 2017-01-19 |
| 2015-06-30 | $40.37K derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-28 | $80.74K derived: sum of 2 quarters · filed 2016-09-28 | $121.11K derived: sum of 3 quarters · filed 2016-09-28 | $161.47K 10-K · filed 2016-09-28 |
| 2015-03-31 | $40.37K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-23 | $80.74K derived: sum of 2 quarters · filed 2016-05-23 | $121.11K 10-Q · filed 2016-05-23 | |
| 2014-12-31 | $40.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-16 | $80.74K 10-Q · filed 2016-02-16 | ||
| 2014-09-30 | $40.37K 10-Q · filed 2015-11-13 | |||
| 2014-06-30 | $161.47K 10-K · filed 2015-10-01 | |||
| 2013-12-31 | $16.75K 10-Q · filed 2015-02-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |